Abstract:Polymeric nanoparticle dispersions containing dexamethasone (DXM) have been prepared from O/W nano-emulsions of the water/polysorbate 80/[4 wt% poly(lactide-co-glycolide) acid+0.18 wt% DXM in ethyl acetate] system by a low-energy method at 25°C. Nano-emulsions were formed at O/S ratios between 45/55 and 72/25 and water contents above 70 wt% by the phase inversion composition (PIC) method. The mean hydrodynamic diameter of nano-emulsions with a constant water content of 90 wt% and O/S ratios from 50/50 to 70/30 was below 350 nm as assessed by dynamic light scattering. The nanoparticles obtained from these nano-emulsions (by solvent evaporation) showed mean diameters of around 130 nm, as determined by transmission electron microscopy image analysis. Therapeutic concentrations of DXM were encapsulated in the nano-emulsions prior to nanoparticle preparation. DXM entrapment efficiency of the nanoparticle dispersion (above 74 wt%) decreased at increasing O/S ratios of the precursor nano-emulsion while DXM loading, which was around 10 mg/100 mL, showed the reverse tendency. DXM release from nanoparticle dispersions was about an order of magnitude slower than from an aqueous solution. In vitro studies performed in a lung carcinoma cell line and in vitro haemolysis studies performed in red blood cells revealed a dose-dependent toxicity and haemolytic response, respectively. The as-prepared nanoparticle dispersions were non-toxic up to a concentration of 40 μg/mL and non-haemolytic up to a concentration of 1 mg/mL. After purification, nanoparticle dispersions were non-toxic up to a concentration of 90 μg/mL. These results allow concluding that these polymeric nanoparticle dispersions are good candidates for inhalatory therapy.

The Preparation of Dexamethasone Acetate Lipid Nanoparticles

Preparation and in vitro characterization of microspheres containing dexamethasone sodium phosphate

Preparation and characterization of Dexamethasone acetate loaded PEG-PLGA nanoparticles

Preparation and optimization of dexamethasone acetate solid lipid nanoparticles by orthogonal design

A Novel Strategy for Encapsulating Poorly Soluble Drug into Nanostructured Lipid Carriers for Intravenous Administration

Optimization of the technological process to prepare Dexamethasone acetate lipid nanoparticles using central composite design-response surface methodology

Optimization of the technological process to prepare Dexamethasone solid lipid nanoparticles

Methoxy Poly（ethylene Glycol）-B-poly（ethyl Cyanoacrylate） Copolymer Nanoparticles As Delivery Vehicles for Dexamethasone

Preparation of Prednisolone Acetate Solid Lipid Nanoparticles

Lung-targeting delivery of dexamethasone acetate loaded solid lipid nanoparticles

Poly(trimethylene Carbonate) and Monomethoxy Poly(ethylene Glycol)-Block-poly(trimethylene Carbonate) Nanoparticles for the Controlled Release of Dexamethasone.

Preparation and in Vivo Pharmacokinetics of Polyethylene Glycol-Modified Nanoparticles Loaded with Dexamethasone Acetate

Release characteristics of dexamethasone acetate solid lipid nanoparticles lyophilized power in vitro

OPTIMIZATION OF PREPARATION OF DEXAMETHASONE ACETATE-LOADED POLY(D,L-LACTIDE) MICROSPHERES BY CENTRAL COMPOSITE DESIGN

Preparation of Dexamethasone Acetate Oral Paste and Its in Vitro Release Characters

Design and in vitro evaluation of biocompatible dexamethasone-loaded nanoparticle dispersions, obtained from nano-emulsions, for inhalatory therapy

Preparation and characterization of hyaluronic acid-modified dexamethasone core-shell liponanoparticles

In Vivo Biodistribution, Anti-Inflammatory, and Hepatoprotective Effects of Liver Targeting Dexamethasone Acetate Loaded Nanostructured Lipid Carrier System

Preparation of diclofenac sodium liposomes by active loading method and its release in vitro

Anti-inflammatory activity of injectable dexamethasone acetate-loaded nanostructured lipid carriers.

Determination of the Loading Amount of Dexamethasone in Dexamethasone-Angelica Sinensis Polysaccharide Prodrugs